as 11-14-2024 4:00pm EST
Founded: | 2018 | Country: | United States |
Employees: | N/A | City: | SOUTH SAN FRANCISCO |
Market Cap: | N/A | IPO Year: | 2021 |
Target Price: | $1.00 | AVG Volume (30 days): | 2.1M |
Analyst Decision: | Sell | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.80 | EPS Growth: | N/A |
52 Week Low/High: | $0.85 - $3.26 | Next Earning Date: | 11-07-2024 |
Revenue: | $63,000 | Revenue Growth: | -99.87% |
Revenue Growth (this year): | -93.72% | Revenue Growth (next year): | N/A |
LYEL Breaking Stock News: Dive into LYEL Ticker-Specific Updates for Smart Investing
Associated Press Finance
7 days ago
GlobeNewswire
7 days ago
GlobeNewswire
9 days ago
Simply Wall St.
13 days ago
GlobeNewswire
14 days ago
MT Newswires
15 days ago
Investing.com
15 days ago
Pharmaceutical Technology
20 days ago
The information presented on this page, "LYEL Lyell Immunopharma Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.